3.8 Article

Seizure remission and improvement of neurological function in sialidosis with perampanel therapy

Journal

EPILEPSY & BEHAVIOR CASE REPORTS
Volume 10, Issue -, Pages 32-34

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ebcr.2018.02.005

Keywords

Progressive myoclonic epilepsy; Sialidosis; Perampanel; NEU1 gene

Ask authors/readers for more resources

A 15-year-old boy experienced myoclonic seizures for 3 years. He initially had occasional myoclonus, gradually progressive ataxia, tremors, and psychomotor and speech regression developed. Eventually, he exhibited nearly continuous myoclonus. He received treatment of sodium valproate, levetiracetam, clobazam, and phenobarbital, without efficacy. A ketogenic diet also proved ineffective. Adjunctive therapy with 4 mg/day of perampanel was started and was gradually titrated to 10 mg/day. The remission of myoclonic seizures was achieved within one month. The patient's neurological and cognitive functions improved to a certain degree during the following 20 months. Sialidosis was confirmed by the mutations of NEU1 gene. (C) 2018 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available